We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Galapagos and Cystic Fibrosis Foundation Therapeutics Announce New Drug Discovery Collaboration

Collaboration aims to identify small molecules derived from natural sources that improve the function of a defective protein found in people who have cystic fibrosis.
News

Abraxis Signs Agreement with Green Cross Corporation for the Commercialization of ABRAXANE in Korea

Green Cross is responsible for the commercialization of ABRAXANE in Korea and will employ an exclusive sales force following regulatory and pricing approval for ABRAXANE.
News

ImmunoVaccine Technologies Completes Scale-Up of VacciMax® to Commercially Relevant Scale

The work validates the suitability of the platform for commercial applications in therapeutic cancer and infectious disease indications.
News

Vermillion Announces Issuance of U.S. Patent Covering Method for Aiding Diagnosis of Kidney Disorder

The U.S. Patent office has issued Vermillion U.S. Patent No. 7,297,556 for aiding diagnosis of nephrotic syndrome.
News

Genedata Provides Expressionist Platform to U.S. Food and Drug Administration

Genedata Expressionist is a computational platform for biomarker discovery that integrates transcriptomics, proteomics and metabolomics data within a single enterprise software system.
News

Thermo Fisher Scientific to Implement Darwin LIMS at APP Pharmaceuticals

Multi-site pharmaceutical manufacturing operation standardizes on Thermo Scientific solution.
News

Pharmacopeia and GlaxoSmithKline Collaboration Identifies two Additional Lead Compounds

The first of the lead compounds forms the basis to develop a treatment for respiratory disease and the other for inflammatory pain.
News

CytRx Reports Favorable Safety and Tolerability Results from High Dose, 28-Day Clinical Trial with Arimoclomol

Results support four-fold higher arimoclomol dose for planned Phase IIb efficacy trial for ALS.
News

ImmunoCellular Therapeutics Agrees to Acquire Molecular Antibody Technology

ImmunoCellular has entered into an agreement with Molecular Discoveries covering the IMUC’s acquisition of all monoclonal antibody related technology owned by MDC.
News

Profiling of Tumor Tissue Slices is Awarded Prize

Novel drug screening tool based on the Bionas® 2500 analyzing system wins silver medal in European business plan contest.
Advertisement